We found CapG specifically promoted PIK3R1/P50 isoform transcription in breast cancer cells, which subsequently triggered activation of PI3K/Akt signaling, resulting in increased cell growth and decreased apoptosis in breast cancer cells exposed to paclitaxel (Figure 7F). Here, NFKB1 is linked to breast carcinoma.